QRCC is pleased to announce the successful completion of a Management Buy Out, effective 28 October 2020, such that Sarah Nicholson, Director and Head of Regulatory and Alex Gage, Director and Head of Clinical Operations are now majority shareholders.
Sarah Fryer continues in her role as Director and Head of Quality, alongside Alex and Sarah, for the foreseeable future but has become a minority shareholder in the company. QRCC has chosen to make this change as part of its succession planning in order to ensure the long-term future of the company as an independent expert consultancy. Sarah Fryer commented ‘I am delighted that this significant change to the structure of QRCC further bolsters the strength of the company’s senior management team, and ensures a robust long-term future for QRCC in what are challenging and unprecedented times’.